The relationship between healthcare companies and physicians is complex, presenting potential conflicts of interest that require oversight. Biopharmaceutical and medical device companies operate in a highly competitive market.  As a result, some companies may seek an advantage by extending gifts or other inappropriate inducements to healthcare professionals to promote a specific drug or medical equipment. […]

Flexing its regulatory muscle, the Food and Drug Administration has warned it would l issue sanctions to pharmaceutical companies which do not comply with the guidelines in following the Mexico City Principles or voluntary code of ethics. Read More at https://medicalobserverph.com/